|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received on November 21, 2008
Accepted on March 27, 2009
Endocrinology and Metabolism |
Core Fragment
1 Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO
2 Department of Clinical Chemistry, Helsinki University Central Hospital, Helsinki, Finland
3 Department of Pathology, Vanderbilt University, Nashville, TN
4 Barnes-Jewish Hospital, St. Louis, MO
* To whom correspondence should be addressed. E-mail: gronowski{at}wustl.edu.
BACKGROUND: During pregnancy, hCG immunoreactivity in urine consists of intact hCG as well as a number of hCG variants including the core fragment of hCG
(hCG
cf). We identified 3 urine specimens with apparent false-negative results using the OSOM® hCG Combo Test (Genzyme Diagnostics) qualitative hCG device and sought to determine whether an excess of 1 of the fragments or variants might be the cause of the interference.
METHODS: We measured concentrations of hCG variants in the urine from 3 patients with apparent false-negative hCG results. Purified hCG variants were added to urines positive for hCG and tested using the OSOM, ICON® 25 hCG (Beckman Coulter), and hCG Combo SP® Brand (Cardinal Health) devices.
RESULTS: Dilution of these 3 urine samples resulted in positive results on the OSOM device. Quantification of hCG variants in each of the 3 patient urine specimens demonstrated that hCG
cf occurred in molar excess of intact hCG. Addition of purified hCG
cf to hCG-positive urines caused false-negative hCG results using the OSOM and ICON qualitative urine hCG devices.
CONCLUSIONS: Increased concentrations of hCG
cf can cause false-negative results on the OSOM and ICON qualitative urine hCG devices.
The following articles in journals at HighWire Press have cited this article:
![]() |
A. M. Gronowski, M. Powers, U. H. Stenman, L. Ashby, and M. G. Scott False-Negative Results from Point-of-Care Qualitative Human Chorionic Gonadotropin (hCG) Devices Caused by Excess hCG{beta} Core Fragment Vary with Device Lot Number Clin. Chem., October 1, 2009; 55(10): 1885 - 1886. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |